Reining in IRB Review in the Revised Common Rule

Area of Science:

• Biomedical Ethics
• Regulatory Science

Background:

• The revised Common Rule introduced changes to streamline oversight of low-risk studies.
• Exempt research categories were expanded, and activities not meeting the definition of research were clarified.

Purpose of the Study:

• To analyze the impact of the revised Common Rule on institutional review board (IRB) jurisdiction.
• To identify unresolved questions regarding IRB review for specific activities.

Main Methods:

• Analysis of the revised Common Rule's text and its implications for regulatory definitions.
• Examination of ambiguities in the definition of "research" and its impact on IRB oversight.

Main Results:

• The revised Common Rule fails to definitively address IRB review for quality assurance activities.
• The distinction between "research" and "public health surveillance" may be unworkable for certain public health initiatives.
• Ambiguities in the "generalizable knowledge" standard for research persist.

Conclusions:

• Despite efforts to reduce regulatory burden, the revised Common Rule leaves significant questions about IRB jurisdiction.
• Further clarification is needed regarding IRB review requirements for quality assurance and public health surveillance.
• The definition of research remains a source of interpretive challenges for IRBs.